New York, New York, United States Valence Life Sciences is the famous VC, which was founded in 2012. The main department of described VC is located in the New York. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Valence Life Sciences, startups are often financed by Kleiner Perkins, InterWest Partners, Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Kleiner Perkins, InterWest Partners, Wexford Capital. In the next rounds fund is usually obtained by Kleiner Perkins, InterWest Partners, HealthCare Royalty Partners.
The higher amount of exits for fund were in 2015. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2012. Opposing the other organizations, this Valence Life Sciences works on 11 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The fund was created by Eric Roberts. We also calculated 2 valuable employees in our database.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Celator Pharmaceuticals, Invuity For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aimyunion | China, Guangdong, Guangzhou |
| Anjos do Brasil | Brazil, São Paulo, Sao Paulo |
| Chengdu Kaisite Electronic Technology | Chengdu, China, Sichuan |
| Coal Hill Ventures | Pennsylvania, Pittsburgh, United States |
| Focus Holdings | - |
| Global Chance Fund | Bayern, Germany, Landshut |
| Groupe Aeroplan | Canada, Montreal, Quebec |
| Hongzhao Fund | China, Futian District, Guangdong Province |
| Lobb Heng Group China | China, Shanghai |
| Mengxiangzhe Dianying | Beijing, Beijing, China |
| NLG Advisors | - |
| Peach Ventures | England, London, United Kingdom |
| PPG Industries | Pennsylvania, Pittsburgh, United States |
| Shiji Ruiyuan Touzi | China, Guangdong Province, Huizhou |
| Translational Research Institute for Space Health (TRISH) | - |
| UBS Oncology Impact Fund | - |
| Walter Ventures | Andalucia, Málaga, Spain |
| Zhongli Hecai Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CalciMedica | $15M | 22 May 2020 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CalciMedica | $15M | 22 May 2020 | San Diego, California, United States |
